-The Hindustan Times The recent release of The Lancet's special edition on Maternal and Child Nutrition in Delhi provided an occasion to debate the relevance of its recommendations for India. The discourse was enlivened by a statement, released ahead of the event by several Indian health experts, challenging the content and intent of some of the suggested interventions. Three authors of The Lancet series and many of the critics who issued that statement...

-Down to Earth     Series of papers calls for engaging private sector in fighting malnutrition Lancet, the world's leading general medical journal, recently published four papers on nutrition. Its plan to release the papers formally in India on Friday has angered the country's public health experts. Lancet has called for engaging private sector in fighting malnutrition. UNICEF estimates say about 46 per cent of all children below three in India are too small...

-Down to Earth     Rural development minister shares concerns of activists at launch of Lancet series; stresses community role in fight against malnutrition India needs to be careful when it comes to agriculture-based nutrition as it opens the door for advocacy for transgenic food, said Jairam Ramesh, Union rural development minister, at the launch of the Lancet Series on Maternal and Child Nutrition. Ramesh was the chief guest at the programme on June...

-The Times of India NEW DELHI: Several nutrition experts and members of the Indian Academy of Paediatrics, the largest association of paediatricians in India, have warned that the new set of papers on malnutrition published in the medical journal, Lancet, "should not be allowed to become an opportunity for commercial exploitation of malnutrition". "The call for engaging with the "private sector" and unregulated marketing of commercial foods for preventing malnutrition in children...

-The Business Standard Data also show that several other leading domestic pharma companies have recalled their products from the US Frequent drug recalls, warning letters and import alerts from the US in the recent past have turned into a major concern for the Indian pharmaceutical industry and investors. While Ranbaxy Laboratories recently pleaded guilty before the US authorities for its wrongdoings in the past, the crackdown on the drug companies seems to...